Drug intelligence / Profile preview

rezenopy

Development stage
Approved
Lead developer
Kindeva Drug Delivery
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Intranasal
01

Overview

Rezenopy is a high-dose nasal spray formulation of naloxone hydrochloride, an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose in adults and pediatric patients. It works by competitively binding to opioid receptors, thereby reversing the life-threatening effects of opioids such as respiratory depression, sedation, and hypotension. Rezenopy delivers 10 mg of naloxone in a single-use pre-filled intranasal device—the highest strength available on the market—and is intended for immediate administration by laypersons or first responders in community settings where opioids may be present. It is not a substitute for emergency medical care; medical assistance should be sought immediately after use. The product was developed to address increasing rates of overdose involving high-potency synthetic opioids[1][2][3][4][5][6][7][8].

Brand names
Rezenopy
Other names
naloxone hydrochloridenaloxone HCl
02

Targets

KOR (Kappa opioid receptor)MOR (Mu opioid receptor)DOR (Opioid Receptor Delta 1)

Beyond the preview

Go deeper on rezenopy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rezenopy.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call